Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.6%

3 terminated out of 35 trials

Success Rate

82.4%

-4.2% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

29%

4 of 14 completed with results

Key Signals

4 with results82% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (21)
Early P 1 (2)
P 1 (1)
P 2 (4)
P 3 (1)

Trial Status

Completed14
Recruiting7
Unknown5
Not Yet Recruiting3
Active Not Recruiting3
Terminated3

Trial Success Rate

82.4%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (35)

Showing 20 of 20 trials
NCT05980169Not ApplicableActive Not Recruiting

The Effect of Low Frequency Soundwave Stimulation on Chemotherapy Induced Peripheral Neuropathy

NCT07427537Not ApplicableRecruiting

Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients

NCT07387653Not Yet RecruitingPrimary

Feasibility and Clinical Utility of Paired Non-Invasive Hemodynamic and Tissue Oximetry Monitoring to Detect Limb Ischemia in Lithotomy-Positioned Surgeries

NCT05410548Not ApplicableCompleted

Comorbidity Screening and Referral by Prosthetists

NCT03858153Phase 2CompletedPrimary

Exercise and Nutrition Interventions During Chemotherapy K07

NCT03037684RecruitingPrimary

Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain

NCT05065554Phase 2Active Not Recruiting

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy

NCT06121232Not ApplicableActive Not RecruitingPrimary

Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study

NCT06912646Not ApplicableRecruiting

Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain

NCT04403802Not ApplicableCompletedPrimary

Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy

NCT05291975Not ApplicableCompleted

Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain

NCT05980767Not ApplicableRecruitingPrimary

Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial

NCT05624138Phase 3RecruitingPrimary

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

NCT05291286Early Phase 1CompletedPrimary

BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients

NCT06512012Not ApplicableCompleted

Technology-Assisted Yoga and Exercise on Neuropathy and Pain in Children With Leukemia

NCT06471517Not ApplicableRecruitingPrimary

Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation

NCT06422949Not ApplicableNot Yet Recruiting

Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy

NCT05480527Not ApplicableUnknownPrimary

Transcutaneous Pulsed Radiofrequency in Diabetic Polyneuropathy

NCT04218448Not ApplicableTerminatedPrimary

Evaluation of the Interest of Hypno-relaxation During Somatosensory Evoked Potentials

NCT03777956Phase 2Terminated

The Effect of Lacosamide in Peripheral Neuropathic Pain

Scroll to load more

Research Network

Activity Timeline